Ultra-high performance liquid chromatography-tandem mass spectrometry for the quantification of icaritin in mouse bone

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 978-979, Issue , 2015, Pages 24-28

  Zhang, Shuang Qing ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Bone; Icaritin; UHPLC MS MS

Indexed keywords

BONE; DISEASES; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MAMMALS; MASS SPECTROMETRY;

ICARITIN; INTRAPERITONEAL ADMINISTRATION; LOWER LIMIT OF QUANTIFICATIONS; ONE-STEP LIQUID-LIQUID EXTRACTIONS; SELECTED REACTION MONITORING; TEMPERATURE CONDITIONS; U-HPLC-MS; ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHIES;

LIQUIDS;

ACETIC ACID ETHYL ESTER; ACETONITRILE; AMMONIUM FORMATE; COUMESTROL; ICARIIN; ICARITIN; ION; UNCLASSIFIED DRUG; WATER; FLAVONOID;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BONE; CALIBRATION; DRUG CLEARANCE; DRUG HALF LIFE; DRUG SOLUBILITY; ELUTION; FLOW RATE; FREEZE THAWING; IN VIVO STUDY; IONIZATION; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; MEAN RESIDENCE TIME; MONITORING; MOUSE; NONHUMAN; PRECURSOR; TANDEM MASS SPECTROMETRY; TEMPERATURE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VOLUME OF DISTRIBUTION; ANIMAL; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPINE; STATISTICAL MODEL;

EPIMEDIUM; MUS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLAVONOIDS; INJECTIONS, INTRAPERITONEAL; LINEAR MODELS; MICE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPINE; TANDEM MASS SPECTROMETRY;

EID: 84919786529     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2014.12.003     Document Type: Article

References (21)

1. Shen P., Wong S.P., Li J., Yong E.L. J. Chromatogr. B 2009, 877:71-78.
2. Wong S.P., Shen P., Lee L., Li J., Yong E.L. J. Pharm. Biomed. Anal. 2009, 50:216-223.
3. Li S., Priceman S.J., Xin H., Zhang W., Deng J., Liu Y., Huang J., Zhu W., Chen M., Hu W., Deng X., Zhang J., Yu H., He G. PLoS ONE 2013, 8:e81657.
4. Sun L., Chen W., Qu L., Wu J., Si J. Mol. Med. Rep. 2013, 8:1883-1887.
5. Tiong C.T., Chen C., Zhang S.J., Li J., Soshilov A., Denison M.S., Lee L.S., Tam V.H., Wong S.P., Xu H.E., Yong E.L. Carcinogenesis 2012, 33:1089-1097.
6. Huang X., Zhu D., Lou Y. Eur. J. Pharmacol. 2007, 564:26-36.
7. Tong J.S., Zhang Q.H., Huang X., Fu X.Q., Qi S.T., Wang Y.P., Hou Y., Sheng J., Sun Q.Y. PLoS ONE 2011, 6:e16781.
8. Lai X., Ye Y., Sun C., Huang X., Tang X., Zeng X., Yin P., Zeng Y. Int. Immunopharmacol. 2013, 16:41-49.
9. Wang Z., Zhang X., Wang H., Qi L., Lou Y. Neuroscience 2007, 145:911-922.
10. Zhu D.Y., Lou Y.J. Acta Pharmacol. Sin. 2005, 26:477-485.
11. Zhang G., Qin L., Sheng H., Wang X.L., Wang Y.X., Yeung D.K., Griffith J.F., Yao X.S., Xie X.H., Li Z.R., Lee K.M., Leung K.S. Bone 2009, 44:345-356.
12. Sheng H., Rui X.F., Sheng C.J., Li W.J., Cheng X.Y., Jhummon N.P., Yu Y.C., Qu S., Zhang G., Qin L. Int. J. Med. Sci. 2013, 10:782-789.
13. Huang J., Yuan L., Wang X., Zhang T.L., Wang K. Life Sci. 2007, 81:832-840.
14. Peng S., Zhang G., Zhang B.T., Guo B., He Y., Bakker A.J., Pan X., Zhen W., Hung L., Qin L., Leung W.N. Bone 2013, 55:230-240.
15. Ming L.G., Chen K.M., Xian C.J. J. Cell Physiol. 2013, 228:513-521.
16. Chang Q., Wang G.N., Li Y., Zhang L., You C., Zheng Y. Phytomedicine 2012, 19:1024-1028.
17. Shen P., Wong S.P., Yong E.L. J. Chromatogr. B 2007, 857:47-52.
18. Zhang S.Q. J. Ethnopharmacol. 2014, 155:1382-1387.
19. European Medicines Agency, (accessed 14.01.13). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
20. Zhang S.Q., Chen X.H., Yu M., Sun X., Li Z.G. J. Chromatogr. B 2012, 880:163-167.
21. Zhang S.Q., Fan Y.M. J. Chromatogr. B 2012, 907:173-177.